ArticleCancers2022

Blinatumomab as a Bridge Therapy for Hematopoietic Stem Cell Transplantation in Pediatric Refractory/Relapsed Acute Lymphoblastic Leukemia.

Katarzyna Pawinska-Wasikowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.